Anti-HOXC9 antibody [HOXCA6E6]
5
(5 Reviews)
|
(18 Publications)
Mouse Monoclonal HOXC9 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 18 publications. Immunogen corresponding to Recombinant Fragment Protein within Human HOXC9.
View Alternative Names
HOX3B, HOXC9, Homeobox protein Hox-C9, Homeobox protein Hox-3B
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HOXC9 antibody [HOXCA6E6] (AB50839)
ab50839 at a 1/5 dilution staining HOXC9 in Hela cells using Alexa Fluor® 488 Goat Anti-mouse IgG at a 1/200 dilution.
- WB
Unknown
Western blot - Anti-HOXC9 antibody [HOXCA6E6] (AB50839)
All lanes:
Western blot - Anti-HOXC9 antibody [HOXCA6E6] (ab50839) at 1/100 dilution
All lanes:
HT-1080 whole cell lysate at 50 µg
Secondary
All lanes:
Mouse IgG antibody at 1/2500 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Genes that HOXC9 regulates play key roles in developmental processes such as neural differentiation and limb formation. HOXC9 might operate as part of a larger transcriptional complex that involves other HOX proteins allowing precise control over developmental gene expression. The protein ensures that cells at different developmental stages respond correctly to morphogenetic signals facilitating proper organismal formation.
Pathways
HOXC9 actively participates in the retinoic acid signaling pathway important for neurodevelopmental regulation. This pathway requires a balance between HOXC9 and Receptor Interacting Protein 1 (RIP1) for correct gene expression. Another critical pathway is the Wnt signaling pathway where HOXC9 interacts with components such as beta-catenin to further modulate gene transcription related to cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:112919 PubMed41054515
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:6310-6335 PubMed39528654
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell stem cell 31:1113-1126.e6 PubMed38981471
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports methods 4:100777 PubMed38744289
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:3745 PubMed38702304
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell stem cell 30:264-282.e9 PubMed36868194
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:105898 PubMed36647382
2023
Applications
Unspecified application
Species
Unspecified reactive species
eLife 11: PubMed36154671
2022
Applications
Unspecified application
Species
Unspecified reactive species
Current protocols 1:e244 PubMed34547185
2021
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 148: PubMed33658223
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com